...M. et al. Cell Chem. Biol.; published online Feb. 8, 2021doi:10.1016/j.chembiol.2021.01.004CONTACT: Masatoshi Hagiwara, Kyoto University, Kyoto, Japanemail: hagiwara.masatoshi.8c@kyoto-u.ac.jp Claire Quang Kyoto University Sphingosine...

...Biol.; published online Sept. 8, 2020doi:10.1016/j.chembiol.2020.08.013CONTACT: Masahiko Ajiro, Kyoto University, Kyoto...
...Japanemail: ajiro.masahiko.6e@kyoto-u.ac.jp CONTACT: Masatoshi Hagiwara, same affiliation as aboveemail: hagiwara.masatoshi.8c@kyoto-u.ac.jp Claire Quang Kyoto University Dual-specificity...

...mutations were therefore tumorigenic changes. In a December paper in Nature , a group from Kyoto University...
...in UC experience divergent selective pressures during subsequent tumor development. Study author Seishi Ogawa, a Kyoto University...
...can be positively or negatively selected depending on the nature of selective pressure." Seishi Ogawa, Kyoto University...

...Sept. 30, 2019 doi:10.1038/s41467-019-12232-3 CONTACT: Gyohei Egawa, Kyoto University, Kyoto, Japan email: gyohei@kuhp.kyoto-u.ac.jp CONTACT: Kenji Kabashima, Kyoto University...
...kaba@kuhp.kyoto-u.ac.jp Claire Quang Gleevac, Gleevec, Glivec, imatinib mesylate (QTI571, CGP 57148B, Ruvise, STI-571) Agency for Science Technology and Research Kyoto University Stem...

...$5 million in milestones. Converting inflammatory T cells to Tregs Astellas Pharma Inc. (Tokyo:4503) and Kyoto University...
...cells. The CDK8/CDK19 inhibitor suppressed autoimmune and allergic immune responses in animal models. Astellas and Kyoto University...

...that space. In 2015, Takeda, the Center for iPS Cell Research and Application (CiRA) and Kyoto University...
...Ltd., London, U.K. Genmab A/S (CSE:GEN; Pink:GMXAY), Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Kyoto University...
...protein 173 Allison Johnson, Senior Writer Adimab LLC Codiak BioSciences Inc. Curadev Pharma Pvt. Ltd. Fujifilm Holdings Corp. GammaDelta Therapeutics Ltd. Genmab A/S Kyoto University Molecular...

...develop and commercialize a novel induced pluripotent stem cell-derived CAR T cell therapy (iCART) from Kyoto University’s...
...are the first iPS cell program from the collaboration to be transferred to Takeda (see "Kyoto University...

...has announced other cell therapy partnerships with Japanese CAR T cell company Noile-Immune Biotech Inc., Kyoto University’s...
...Biotechnologies GmbH, Tuebingen, Germany Incysus Therapeutics Inc., New York, N.Y. King’s College London, London, U.K. Kyoto University...

...Sakaguchi, Kyoto University, Kyoto, Japan email :shimon@ifrec.osaka-u.ac.jp CONTACT: Keiji Hirota, Osaka University, Osaka, Japan email: hkeiji@infront.kyoto-u.ac.jp Claire Quang Kyoto University Osaka...

...as multiple sclerosis, psoriasis and rheumatoid arthritis. This month, researchers at University of Florida and Kyoto University...
...mice with normal SATB1 levels. Senior author Keiji Hirota, a professor of pharmaceutical sciences at Kyoto University...